Doorbraak in behandeling van baby’s met agressieve leukemie Een nieuwe immuuntherapie voor baby’s met een agressieve vorm van leukemie vergroot de overlevingskansen aanzienlijk, blijkt uit nieuw onderzoek...
Latest articles
From silos to systems: Powering omnichannel marketing
From silos to systems: Powering omnichannel marketing Effective approaches shared during a Convene webinar for integration and creating a seamless experience. Despite the quest for omnichannel activation in pharma...
Five things for pharma marketers to know: Tuesday, April 25, 2023
Five things for pharma marketers to know: April 25 Bluebird Bio submitted an application for its sickle cell therapy lovo-cel to the Food and Drug Administration for approval. The FDA put another Foghorn Therapeutics...
EMA validates marketing authorisation application for Jemperli with chemotherapy
EMA validates marketing authorisation application for Jemperli GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication for Jemperli (dostarlimab)...
FDA Approves Cord Blood Stem Cell Product, Omisirge, for Blood Cancer Patients
FDA Approves Cord Blood Stem Cell Product, Omisirge, for Blood Cancer Patients The U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic cord blood-based cell...
The Wild West of cannabis marketing
The Wild West of cannabis marketing Patient and consumer interest couldn’t be higher. Here’s how marketers can meet demand. It’s a noisy frontier, full of confusing rules and messages. There’s no definitive playbook for...
